Sharon Barr

SVP, Head of Research and Product Development

Sharon Barr is Senior Vice President, Head of Research and Product Development of Alexion, AstraZeneca Rare Disease.

Headshot of Sharon Barr

About Sharon

Sharon is responsible for drug discovery and early development as well as discovery and development of diagnostics, data sciences, genomics, bioinformatics, clinical biomarkers, and bioanalytical sciences supporting the Alexion pipeline. With more than 18 years of industry experience she has previously led translational research, precision medicines, and global drug development teams at small and large companies.

Sharon received her PhD in molecular biology from New York University, and completed a postdoctoral fellowship on Mechanisms of DNA Damage and Repair at Stanford University.

Joe, diagnosed with PNH at 24 years old, training for mixed martial arts
If anything, living with PNH has made me appreciate my time even more, and given me more drive to get back to doing what I love to do.”